FV HR2 Haplotype as Additional Inherited Risk Factor for Deep Vein Thrombosis in Individuals with a High-Risk Profile
暂无分享,去创建一个
M. Margaglione | E. Grandone | G. Di Minno | G. D’Andrea | V. Brancaccio | A. Ciampa | A. Bossone | Donatella Coalizzo
[1] D. Girelli,et al. Functional Properties of Factor V and Factor Va Encoded by the R2-gene , 2001, Thrombosis and Haemostasis.
[2] F. Rosendaal,et al. The HR2 Haplotype of Factor V: Effects on Factor V Levels, Normalized Activated Protein C Sensitivity Ratios and the Risk of Venous Thrombosis , 2000, Thrombosis and Haemostasis.
[3] D. Girelli,et al. Mutations in the R2 FV Gene Affect the Ratio between the Two FV Isoforms in Plasma , 2000, Thrombosis and Haemostasis.
[4] T. Baglin,et al. The Factor V R2 Allele: Risk of Venous Thromboembolism, Factor V Levels and Resistance to Activated Protein C , 2000, Thrombosis and Haemostasis.
[5] F R Rosendaal,et al. Risk Factors for Venous Thrombotic Disease , 1999, Thrombosis and Haemostasis.
[6] A. Tosetto,et al. Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous Thromboembolism , 1999, Annals of Internal Medicine.
[7] F. Rosendaal,et al. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. , 1999, Blood.
[8] V. Nicaud,et al. The Factor V Gene A4070G Mutation and the Risk of Venous Thrombosis , 1999, Thrombosis and Haemostasis.
[9] M. Margaglione,et al. Increased Risk for Venous Thrombosis in Carriers of the Prothrombin GA20210 Gene Variant , 1998, Annals of Internal Medicine.
[10] M. Margaglione,et al. The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin , 1998, Thrombosis and Haemostasis.
[11] M. Makris,et al. Co-inheritance of the 20210A Allele of the Prothrombin Gene Increases the Risk of Thrombosis in Subjects with Familial Thrombophilia , 1997, Thrombosis and Haemostasis.
[12] A. Cumming,et al. The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population , 1997, British journal of haematology.
[13] E. Sacchi,et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. , 1997, Blood.
[14] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[15] P. Mannucci,et al. Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.
[16] J. Rosing,et al. Factor V Enhances the Cofactor Function of Protein S in the APC-Mediated Inactivation of Factor VIII: Influence of the Factor VR506Q Mutation , 1996, Thrombosis and Haemostasis.
[17] A. Tosetto,et al. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. , 1996, American journal of epidemiology.
[18] P. Mannucci,et al. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. , 1996, Blood.
[19] P. Reitsma,et al. Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency , 1996, Thrombosis and Haemostasis.
[20] N. Dzimiri,et al. World distribution of factor V Leiden , 1996, The Lancet.
[21] P. Reitsma,et al. Factor V Leiden: An Additional Risk Factor for Thrombosis in Protein S Deficient Families? , 1995, Thrombosis and Haemostasis.
[22] J. Griffin,et al. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. , 1995, Blood.
[23] P. Reitsma,et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994, Blood.
[24] J. Birkmeyer,et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. , 1994, Archives of internal medicine.
[25] J. Miletich,et al. Inherited predisposition to thrombosis , 1993, Cell.
[26] H. Büller,et al. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.